stella
beta
Ensartinib as Adjuvant Treatment in Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung Cancer — Stella
Home
/
Non-small Cell Lung Cancer
/
View on ClinicalTrials.gov
Recruiting
Back to Non-small Cell Lung Cancer trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
China
TianJin Medical University Cancer Institute & Hospital, Tianjin